Amyloid β peptide (Aβ) is a key player in the development of Alzheimer’s disease (AD). It is the primary component of senile plaques in AD patients and is also found in soluble forms. Cholinergic activity mediated by α7 nicotinic receptors has been shown to be affected by Aβ soluble forms. To shed light into the molecular mechanism of this effect, we explored the direct actions of oligomeric Aβ 140 and Aβ 142 on human α7 by fluorescence spectroscopy and single-channel recordings. Fluorescence measurements using the conformational sensitive probe crystal violet (CrV) revealed that in the presence of Aβ α7 undergoes concentration-dependent conformational changes. Exposure of α7 to 100 pM Aβ changes CrV K D towards that of the desensitized sta...
(E)-5-(Pyrimidin-5-yl)-1,2,3,4,7,8-hexahydroazocine (TC299423) is a novel agonist for nicotinic acet...
The presence in patient’s brain tissues of neuritic plaques containing Aβ aggregates is one of the p...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease in which the formation of extrac...
The self-assembly of amyloid peptides (Aβ), in particular Aβ1–42, into oligomers and fibrils is one ...
Introduction A general characteristic of aggregation is the multiple interaction and cross-feedback...
Alzheimer's Disease (AD) is a progressive, age-related disease that is positively characterised by ...
AbstractThe “amyloid-β (Aβ) hypothesis” posits that accumulating Aβ peptides (Aβs) produced by neuro...
The Amyloid-β (Aβ) peptide is the main component of the the amyloid plaques in Alzheimer’s Disease (...
Alzheimer’s disease (AD) is characterized by the deposition of aggregated species of amyloid beta (A...
αLβ2 is expressed on all leukocytes and plays a major role in immune responses by regulating cell ad...
Parkinson's disease (PD) is a neurodegenerative disorder for which only symptomatic treatments are a...
Hyperosmolarity is a key controversial signal for renal cells. Under physiological conditions, it in...
Bien que la maladie d’Alzheimer (MA) soit la cause de démence la plus fréquente, lesmécanismes qui s...
La maladie d’Alzheimer (MA) est définie comme une maladie neurodégénérative où des altérations synap...
© 2018 Dr. Mariusz MitalCompleted under a Cotutelle arrangement between the University of Melbourne ...
(E)-5-(Pyrimidin-5-yl)-1,2,3,4,7,8-hexahydroazocine (TC299423) is a novel agonist for nicotinic acet...
The presence in patient’s brain tissues of neuritic plaques containing Aβ aggregates is one of the p...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease in which the formation of extrac...
The self-assembly of amyloid peptides (Aβ), in particular Aβ1–42, into oligomers and fibrils is one ...
Introduction A general characteristic of aggregation is the multiple interaction and cross-feedback...
Alzheimer's Disease (AD) is a progressive, age-related disease that is positively characterised by ...
AbstractThe “amyloid-β (Aβ) hypothesis” posits that accumulating Aβ peptides (Aβs) produced by neuro...
The Amyloid-β (Aβ) peptide is the main component of the the amyloid plaques in Alzheimer’s Disease (...
Alzheimer’s disease (AD) is characterized by the deposition of aggregated species of amyloid beta (A...
αLβ2 is expressed on all leukocytes and plays a major role in immune responses by regulating cell ad...
Parkinson's disease (PD) is a neurodegenerative disorder for which only symptomatic treatments are a...
Hyperosmolarity is a key controversial signal for renal cells. Under physiological conditions, it in...
Bien que la maladie d’Alzheimer (MA) soit la cause de démence la plus fréquente, lesmécanismes qui s...
La maladie d’Alzheimer (MA) est définie comme une maladie neurodégénérative où des altérations synap...
© 2018 Dr. Mariusz MitalCompleted under a Cotutelle arrangement between the University of Melbourne ...
(E)-5-(Pyrimidin-5-yl)-1,2,3,4,7,8-hexahydroazocine (TC299423) is a novel agonist for nicotinic acet...
The presence in patient’s brain tissues of neuritic plaques containing Aβ aggregates is one of the p...
Alzheimer’s disease (AD) is a progressive neurodegenerative disease in which the formation of extrac...